A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis

Status unconfirmed · Not applicable

Conditions studied: Cryptosporidiosis, HIV Infections

In brief

The purpose of this study is to see if nitazoxanide (NTZ) can be used to treat AIDS patients suffering from cryptosporidiosis (diarrhea caused by the parasite Cryptosporidium).

Key facts

Study ID

NCT00002158

Run by

Romark Laboratories L.C.

Last updated by the study team

2007-07-10

Who can join

Age: 3 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients may be eligible for this study if they:
• Are 3 to 65 years old (need consent of parent or guardian if under 18).
• Have AIDS.
• Have a CD4 count less than or equal to 200 cells/mm3. (Note: Patients with a CD4 count greater than 200 cells/mm3 but who have had cryptosporidiosis for at least 4 weeks may be eligible for this study.)
• Test positive for the parasite Cryptosporidium and have severe diarrhea (at least 4 bowel movements per day) for at least 2 weeks.
• Have received treatment for cryptosporidiosis but have become reinfected after treatment.
• Agree to practice abstinence or use effective methods of birth control (such as a condom) before and during the study.

You may not qualify if…

• Patients will not be eligible for this study if they:
• Are pregnant.
• Are infected with certain other parasites.
• Have a history of certain intestinal diseases.
• Have received certain medications.

Where it is running

• Romark Laboratories LC — Tampa, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.